rs1057516033
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_012330.4(KAT6B):c.3664+1G>A variant causes a splice donor, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_012330.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Genitopatellar syndrome Pathogenic:1
The variant is not observed in the gnomAD v2.1.1 dataset. Previously reported to alter splicing and result in a loss of normal protein fucnction through nonsense-mediated decay (NMD) or protein truncation (ClinVar ID: RCV000023482). The variant has been reported to be associated with KAT6B -related disorder (ClinVar ID: VCV000369663). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
Blepharophimosis - intellectual disability syndrome, SBBYS type Pathogenic:1
This substitution is located at the first base of intron 17 of the KAT6B gene and is predicted to disrupt the 5' donor splice site, causing retention of intron 17 within the KAT6B transcript and introducing an in-frame stop codon two amino acids past the end of exon 17. This variant is novel and is predicted to be deleterious by in-silico models. It has been confirmed to be de novo. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at